| Bioactivity | Neuropeptide W-23 (human) (NPW-23) TFA, the active form of Neuropeptide W, is an endogenous agonist of NPBW1 (GPR7) and NPBW2 (GPR8)[1]. |
| Invitro | Neuropeptide W-23 (human) (NPW-23) increases the ICa,L in transfected human embryonic kidney 293 cells and VSMCs via GPR7[1]. Neuropeptide W-23 (human) increases the expression of pan phospho-PKC, intracellular diacylglycerol level, and the second messenger catalyzed by PLC[1]. |
| Name | Neuropeptide W-23 (human) (TFA) |
| Sequence | Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-LeuMet-Gly-Leu |
| Shortening | WYKHVASPRYHTVGRAAGLLMGL |
| Formula | C119H183N35O28S.C2HF3O2 |
| Molar Mass | 2698.03 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Neuropeptide W-23 (human) (TFA)
CAS: F: C119H183N35O28S.C2HF3O2 W: 2698.03
Neuropeptide W-23 (human) (NPW-23) TFA, the active form of Neuropeptide W, is an endogenous agonist of NPBW1 (GPR7) and
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.